TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia.
Cancer cachexia is a debilitating condition characterized by a combination of anorexia, muscle wasting, weight loss, and malnutrition. This condition affects an overwhelming majority of patients with pancreatic cancer and is a primary cause of cancer-related death. However, few, if any, effective th...
Main Authors: | Stephanie H Greco, Lena Tomkötter, Anne-Kristin Vahle, Rae Rokosh, Antonina Avanzi, Syed Kashif Mahmood, Michael Deutsch, Sara Alothman, Dalia Alqunaibit, Atsuo Ochi, Constantinos Zambirinis, Tasnima Mohaimin, Mauricio Rendon, Elliot Levie, Mridul Pansari, Alejandro Torres-Hernandez, Donnele Daley, Rocky Barilla, H Leon Pachter, Daniel Tippens, Hassan Malik, Allal Boutajangout, Thomas Wisniewski, George Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0132786 |
Similar Items
-
γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation
by: Daley, D, et al.
Published: (2016) -
Cancer cachexia: Focus on cachexia factors and inter-organ communication
by: Yongfei Wang, et al.
Published: (2024-01-01) -
Differential Diagnosis of Cachexia and Refractory Cachexia and the Impact of Appropriate Nutritional Intervention for Cachexia on Survival in Terminal Cancer Patients
by: Nobuhisa Nakajima
Published: (2021-03-01) -
Pathogenetic aspects of cachexia
by: Irina S. Klochkova, et al.
Published: (2020-06-01) -
Cachexia and advanced dementia
by: Cecilia Minaglia, et al.
Published: (2019-04-01)